Streptococcal Infections Clinical Trial
Official title:
Efficacy of Brazilian Green Propolis Varnish Against Streptococcus Mutans in Saliva: a Phase II Study.
This study aims to evaluate the effectiveness of a varnish containing 15% of green propolis on Streptococcus mutans in saliva and biofilm. Will be invited to join the study: children 8-10 years old, free of caries, without orthodontic appliances and without having undergone antibiotic therapy until three weeks before the start of the study. Saliva will be collected before, immediately after, 24 hours and 30 days after application of the varnish. The collection of biofilm will be performed before, after, 24 hours and 30 days after application of the varnish. Data will be collected and compared between periods.
Status | Completed |
Enrollment | 11 |
Est. completion date | July 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 8 Years to 10 Years |
Eligibility |
Inclusion Criteria: - children 8-10 years old - good general health condition - not making use of mouthwashes or medications (especially antibiotics), until three weeks prior to the beginning of the experiment. Exclusion Criteria: - Patients in medical treatment or who used drugs (especially antibiotics), in the three previous weeks and patients with active caries lesions. |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Federal University of Minas Gerais | Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Streptococcus mutans in saliva and in tooth biofilm | 30 days | Yes | |
Secondary | Caries incidence reduction | Up to 24 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01412801 -
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings
|
Phase 2 | |
Completed |
NCT00884728 -
Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory
|
N/A | |
Completed |
NCT01193920 -
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age
|
Phase 1/Phase 2 | |
Terminated |
NCT00261742 -
Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis
|
Phase 4 | |
Completed |
NCT00169481 -
A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine
|
Phase 2 | |
Completed |
NCT02270944 -
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
|
Phase 2 | |
Completed |
NCT03055728 -
Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis
|
||
Withdrawn |
NCT00598429 -
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
|
Phase 2 | |
Completed |
NCT01030731 -
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
|
Phase 1 | |
Completed |
NCT04100772 -
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
|
Phase 1 | |
Completed |
NCT01118143 -
Oral Health Literacy Tailored Communication
|
N/A | |
Completed |
NCT01026740 -
Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
|
Phase 1 | |
Withdrawn |
NCT00330642 -
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study
|
N/A | |
Completed |
NCT00299663 -
Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract
|
N/A | |
Completed |
NCT00646958 -
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
|
Phase 2 | |
Completed |
NCT01026636 -
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
|
Phase 1 | |
Completed |
NCT00514527 -
A Study for Patients With Complicated Skin and Skin Structure Infections
|
Phase 2 | |
Completed |
NCT01026558 -
A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
|
Phase 1 | |
Completed |
NCT01156740 -
Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings
|
N/A | |
Completed |
NCT04841369 -
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)
|
Phase 3 |